When a global pandemic strikes, it’s important to use the resources at your disposal to help others. According to a recent FiercePharma article, Swiss-based pharma giant Novartis is doing its part by promising zero profit from sales of 15 generic and over-the-counter drugs that manage COVID-19 symptoms in developing countries. The medicines, all from Novartis’ Sandoz unit, include widely used antibiotics and anti-inflammatory therapies and medications for cardiovascular and gastrointestinal diseases. On top of that, Novartis has pledged to donate $40 million to support communities affected by the pandemic.
Novartis to Forgo COVID-19 Profits in Developing Countries
The company’s generic division will offer 15 medicines at zero profit.